Systemic Lupus Erythematosus in Children and Adolescents

https://doi.org/10.1016/j.pcl.2012.03.007Get rights and content

Section snippets

Epidemiology

Childhood-onset SLE (cSLE) is a rare disease with an incidence of 0.3 to 0.9 per 100,000 children-years and a prevalence of 3.3 to 8.8 per 100,000 children.1 A higher frequency of cSLE is reported in Asians, African Americans, Hispanics, and Native Americans.2, 3 When compared with 2 more common childhood autoimmune diseases, juvenile idiopathic arthritis (JIA) and type 1 diabetes, cSLE is approximately 10 to 15 times less common in White children.4, 5 However, in Asian children, cSLE is

Classification and diagnosis of cSLE

SLE is called the great mimicker, as the disease shares characteristics with many other (autoimmune) diseases. Especially when the classic malar rash is absent, diagnosing SLE can be a challenge. However, the astute pediatrician who considers SLE when presented with an unusual constellation of symptoms can recognize important patterns of disease manifestations crucial for the diagnosis. Most patients who are diagnosed with cSLE fulfill 4 or more of the American College of Rheumatology

Clinical features

This review does not attempt to describe all possible clinical manifestations but instead focuses on specific features that may be crucial for immediate recognition. Table 2 summarizes the frequencies of the common manifestations of cSLE.7, 12, 13, 14, 15, 16, 17 SLE can affect any organ system, and leads to glomerulonephritis and central nervous system (CNS) involvement arguably more often in cSLE than in adults with SLE.

Is it SLE?

The differential diagnosis of SLE is broad, and includes infection, malignancy, and other inflammatory disorders. The adolescent female patient who presents with a photosensitive malar rash, painless oral ulcer, polyarthritis, Raynaud phenomenon, and pleural effusions is not a diagnostic challenge. However, initial symptoms may be vague, and red flags for the pediatrician include an older child or adolescent with any combination of persistent fever, fatigue, anemia, leukopenia,

Complications

In addition to severe disease flares and complications secondary to medications, 2 further categories warrant mention: infection and MAS.

Treatment

The care of a child or adolescent with SLE requires a multidisciplinary approach, and ideally involves rheumatology, a primary care physician, nephrology (for any patient with renal disease), adolescent medicine, psychiatry and psychology, nursing, social work, and physical and occupational therapy. Pharmacologic treatment is often aggressive, but tailored to the severity and extent of disease manifestations. Although few drugs are actually approved by the Food and Drug Administration (FDA) for

Adolescent issues to consider for optimal disease management

SLE is a lifelong disease, characterized by periods of flare and remission. Because the typical cSLE patient is an adolescent female, addressing the usual challenges of adolescence becomes crucial to ensuring that the adolescents are making informed and correct choices. As the onset of SLE occurs at an already challenging time in life, further stresses and comorbidities of disease should be minimized. At this age, teens are trying to exert their independence, are learning self-sufficiency

Long-term outlook

Studies have shown that patients with SLE do not achieve long-lasting drug-free remission, and many patients have persistently active disease requiring long-term immunosuppressive treatment.61, 62 However, cSLE patients are younger at diagnosis and have a more severe disease course than those with adult-onset SLE, therefore they are prone to develop significant damage caused by the disease or its treatment at a relatively young age.7, 63 Nonwhite ethnicity, especially African American (or

Summary

Childhood-onset SLE is a lifelong autoimmune disease that may be difficult to diagnose because of its multisystem involvement and heterogeneity of clinical manifestations. It follows a more aggressive disease course than adult-onset SLE, with greater disease activity at presentation and over time, and consequently leads to greater morbidity and mortality than adult-onset SLE. Moreover, children with SLE have to deal with this unpredictable, relapsing-remitting disease during adolescence, an

First page preview

First page preview
Click to open first page preview

References (74)

  • F.R. Pluchinotta et al.

    Distinctive clinical features of pediatric systemic lupus erythematosus in three different age classes

    Lupus

    (2007)
  • M.C. Hochberg

    Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

    Arthritis Rheum

    (1997)
  • E.M. Tan et al.

    The 1982 revised criteria for the classification of systemic lupus erythematosus

    Arthritis Rheum

    (1982)
  • M.B. Ferraz et al.

    Evaluation of the 1982 ARA lupus criteria data set in pediatric patients. Committees of Pediatric Rheumatology of the Brazilian Society of Pediatrics and the Brazilian Society of Rheumatology

    Clin Exp Rheumatol

    (1994)
  • L.A. Ramirez Gomez et al.

    Childhood systemic lupus erythematosus in Latin America. The GLADEL experience in 230 children

    Lupus

    (2008)
  • W.L. Sibbitt et al.

    The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus

    J Rheumatol

    (2002)
  • L.C. Wang et al.

    Retrospective analysis of mortality and morbidity of pediatric systemic lupus erythematosus in the past two decades

    J Microbiol Immunol Infect

    (2003)
  • E. Descloux et al.

    Influence of age at disease onset in the outcome of paediatric systemic lupus erythematosus

    Rheumatology (Oxford)

    (2009)
  • Y. Uziel et al.

    Outcome of a national Israeli cohort of pediatric systemic lupus erythematosus

    Lupus

    (2007)
  • S. Salah et al.

    Systemic lupus erythematosus in Egyptian children

    Rheumatol Int

    (2009)
  • M.C. Sampaio et al.

    Discoid lupus erythematosus in children—a retrospective study of 34 patients

    Pediatr Dermatol

    (2008)
  • K.H. Costenbader et al.

    Trends in the incidence, demographics and outcomes of end-stage renal disease due to lupus nephritis in the U.S., 1995-2006

    Arthritis Rheum

    (2011)
  • C. Fiehn et al.

    Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment

    Ann Rheum Dis

    (2003)
  • L.T. Hiraki et al.

    End-stage renal disease due to lupus nephritis among children in the U.S., 1995-2006

    Arthritis Rheum

    (2011)
  • P. Cochat et al.

    Disease recurrence in paediatric renal transplantation

    Pediatr Nephrol

    (2009)
  • The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes

    Arthritis Rheum

    (1999)
  • S.M. Benseler et al.

    Neuropsychiatric involvement in pediatric systemic lupus erythematosus

    Lupus

    (2007)
  • H.I. Brunner et al.

    Lupus headaches in childhood-onset systemic lupus erythematosus: relationship to disease activity as measured by the systemic lupus erythematosus disease activity index (SLEDAI) and disease damage

    Lupus

    (2003)
  • D.D. Mitsikostas et al.

    A meta-analysis for headache in systemic lupus erythematosus: the evidence and the myth

    Brain

    (2004)
  • D.M. Levy et al.

    Thromboembolism in paediatric lupus patients

    Lupus

    (2003)
  • S. Singh et al.

    Neuropsychiatric manifestations and antiphospholipid antibodies in pediatric onset lupus: 14 years of experience from a tertiary center of North India

    Rheumatol Int

    (2009)
  • T.S. Williams et al.

    Neurocognitive impairment in childhood-onset systemic lupus erythematosus: measurement issues in diagnosis

    Arthritis Care Res (Hoboken)

    (2011)
  • H.I. Brunner et al.

    Initial validation of the pediatric automated neuropsychological assessment metrics for childhood-onset systemic lupus erythematosus

    Arthritis Rheum

    (2007)
  • D.M. Levy et al.

    Neurocognitive impairment in children and adolescents with systemic lupus erythematosus

    Nat Clin Pract Rheumatol

    (2009)
  • J.M. Pego-Reigosa et al.

    Psychosis due to systemic lupus erythematosus: characteristics and long-term outcome of this rare manifestation of the disease

    Rheumatology (Oxford)

    (2008)
  • K.Y. Fong et al.

    Neuropsychiatric lupus: clinical challenges, brain-reactive autoantibodies and treatment strategies

    Lupus

    (2010)
  • S. Appenzeller et al.

    Epileptic seizures in systemic lupus erythematosus

    Neurology

    (2004)
  • Cited by (201)

    View all citing articles on Scopus
    View full text